2 Sources
[1]
Wishpond Collaborates with Venops to Transform Professional Medical Engagements with AI-Powered SalesCloser Platform - Wishpond Techs (OTC:WPNDF)
Wishpond enters into a collaboration agreement with Venops to market and sell Wishpond's AI-powered SalesCloser platform, white-labeled as Provencis, to clients in healthcare and the medical industry.This collaboration underscores Wishpond's commitment to expanding SalesCloser's reach into new
[2]
Wishpond Collaborates with Venops to Transform Professional Medical Engagements with AI-Powered SalesCloser Platform
VANCOUVER, BC, March 27, 2025 /PRNewswire/ - Wishpond Technologies Ltd. (TSXV: WISH) (OTCQX: WPNDF) (the "Company" or "Wishpond"), a provider of AI-enabled marketing-focused online business solutions, is pleased to announce a collaboration agreement with Venops Inc. ("Venops"), a leader in
Share
Copy Link
Wishpond Technologies Ltd. partners with Venops Inc. to introduce an AI-powered sales platform, branded as Provencis, to the medical industry, aiming to revolutionize patient care and sales processes in healthcare.

Wishpond Technologies Ltd., a provider of AI-enabled marketing solutions, has announced a groundbreaking collaboration with Venops Inc., a leader in healthcare regulatory compliance and consulting services. The partnership aims to introduce Wishpond's AI-powered SalesCloser platform, rebranded as "Provencis," to the medical industry
1
.Provencis is a healthcare-focused generative AI solution designed to assist providers with patient care, administrative tasks, and sales operations. The platform offers a range of applications tailored for different segments of the medical industry:
2
.The collaboration between Wishpond and Venops marks a significant step forward in the application of AI within the healthcare industry. Provencis is designed to be a scalable and cost-effective AI-powered platform that helps healthcare organizations manage high volumes of inquiries while reducing reliance on human representatives
1
.Related Stories
The partnership leverages Venops' network of over 1,000 medical clinics and its expertise in healthcare compliance, combined with Wishpond's innovative AI technology. This collaboration aims to revolutionize how businesses in the medical sector engage with prospects and drive sales
2
.Ali Tajskandar, CEO of Wishpond, emphasized the company's commitment to expanding SalesCloser's reach into new verticals, while Mark Maloney, CEO of Venops, highlighted the potential of Provencis to transform how businesses engage with prospects and drive sales in the medical sector
1
.As AI continues to reshape the healthcare landscape, the Wishpond-Venops collaboration represents a significant step towards creating a future where AI helps the healthcare ecosystem focus on what truly matters: the patient. By combining Wishpond's expertise in AI-driven automation with Venops' regulatory knowledge, Provencis has the potential to redefine how healthcare businesses interact with patients and manage their sales operations, ultimately driving better outcomes for providers and patients alike.
Summarized by
Navi
19 Aug 2024

23 Oct 2024•Business and Economy

09 Jan 2025•Technology

1
Technology

2
Science and Research

3
Technology
